Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMMAd for Faecal Incontinence
NCT02292628Phase 2Completed
- Start
- Oct 2013
- Primary completion
- Sep 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CMMAd in fecal incontinence (FI). Started Oct 2013; status: completed.
02
Drugs
CMMAd
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT02292628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02292628.